This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Mizuho Medy Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Kensuke Miyajima: Innovator in Nucleic Acid Detection
Introduction
Kensuke Miyajima is a notable inventor based in Japan, recognized for his contributions to the field of molecular biology. He has developed innovative solutions that enhance the detection of multiple target nucleic acids, which is crucial for various applications in genetic research and diagnostics.
Latest Patents
Miyajima's most significant patent is titled "Kit For Together Detecting Multiple Target Nucleic Acids Differing From Each Other And Detection Method Using The Same." This detection kit allows for the simultaneous amplification and detection of multiple genes using a single reaction container. The kit includes a solution that may contain two different target nucleic acids, each capable of dissociating at a specific denaturation temperature. The innovative design incorporates DNA polymerase, primers, and probes that work together to ensure accurate detection of the target nucleic acids.
Career Highlights
Kensuke Miyajima is currently associated with Mizuho Medy Co., Ltd., where he continues to advance his research and development efforts. His work has significantly impacted the field of nucleic acid detection, providing researchers with more efficient tools for genetic analysis.
Collaborations
Miyajima collaborates with esteemed colleagues such as Takashi Nagano and Kenji Narahara, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Kensuke Miyajima's work in developing a detection kit for multiple target nucleic acids showcases his commitment to advancing molecular biology. His contributions are vital for enhancing the accuracy and efficiency of genetic research and diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile